Study confirms malabsorption is a sign of celiac disease

May 4, 2022

A large observational cohort study conducted in Copenhagen confirmed that malabsorption is associated with celiac disease, according to researchers.The findings were published in Scientific Reports.“This study identified several biochemical abnormalities associated with celiac disease (CD) antibody positivity in a primary care setting among individuals referred to CD antibody testing,” Line Lund Kårhus, MD, PhD, the head of epidemiology at Frederiksberg Hospital in Denmark, and colleagues wrote. “The pattern of abnormalities suggested that micronutrient deficienciesRead More

Categories: News

IBD incidence, prevalence on the rise in Denmark with shift toward older patients

The incidence and prevalence of inflammatory bowel disease have increased in Denmark over the past two decades, most notably prevalence of ulcerative colitis among adults…

August 25, 2022

TNF inhibitors pose ‘modest risk’ for new-onset psoriasis

Patients with immune mediated diseases and treated with tumor necrosis factor-alpha inhibitors have a modest risk for new onset psoriasis, according to a study.“Biologics are…

July 15, 2022

Navigating the Legislative Tides: A Mid-Session Update from the Florida Gastroenterologic Society

As the 2024 Legislative Session in Florida strides past its one-third mark, the Florida Gastroenterologic Society (FGS) remains actively engaged, monitoring and influencing healthcare legislation that impacts gastroenterologists across the state. While thousands of bills are in the mix, only a select few have garnered significant attention. Here’s a concise overview of the key bills and initiatives that FGS is closely watching:

Justin Bouck January 30, 2024

Third COVID vaccine provides ‘significant boost’ in antibody response in patients with IBD

Immunosuppressed patients with inflammatory bowel disease who received a third COVID-19 vaccine demonstrated improved antibody binding, although the response was reduced in patients receiving infliximab…

September 30, 2022

Q&A: Noninvasive liquid biopsy test could be ‘game changer’ for NASH, liver fibrosis

A noninvasive liquid biopsy test diagnosed the presence and severity of nonalcoholic steatohepatitis and liver fibrosis more reliably than liver biopsy, according to research published…

July 27, 2022

Related Articles